Table 2.
Ginkgo or ginkgolide | Experimental model | Proposed mechanism(s) | Ref |
Ginkgo extract | Adriamycin treated rats | antioxidant | [65] |
Adriamycin treated mice | antioxidant | [66] | |
Adriamycin treated rats | reduced apoptosis | [67] | |
Adriamycin treated rats | increased NO generation antioxidant | [68] | |
Isoproterenol treated rats | antioxidant | [69] | |
Isoproterenol treated rats | increased NO generation | [70] | |
Isoproterenol treated NRVM | improved NO generation | [68] | |
STZ treated AP mice | reduced apoptosis | [71] | |
reduced inflammatory response | |||
Mice viral myocarditis | decreased S100A4 and MMP-3 expression | [73] | |
Ginkgolide B | Ang II induced H9c2 | increased autophagy | [83] |
Ginkgolide A | Mouse CAL | reduced inflammatory response | [84] |
Ang II induced NRVM hypertrophy | reduced inflammatory response | [84] | |
LPS-induced sepsis in mice | decreased nuclear FoxO1 | [85] |
Table represents main findings of the specific study. See text for details. Definitions of abbreviated terms as follows: Ang II, angiotensin II; CAL, coronary artery ligation; FoxO1, Forkhead box protein O1; MMP-3, matrix metalloproteinase-3; NO, nitric oxide; NRVM, neonatal rat ventricular myocytes; S100A4, S100 calcium-binding protein A4; STZ, streptozotocin; LPS, lipopolysaccharide.